Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma

References

• Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67–76.
   PubMed Web of Science ®Google Scholar
• Carlos de Vicente J, Junquera Gutiérrez LM, Zapatero AH, Fresno Forcelledo MF, Hernandez-Vallejo G, López Arranz JS. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck. 2004;26:22–30.
   PubMed Web of Science ®Google Scholar
• Guerra MF, Campo FJ, Gias LN, Perez JS. Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation. Head Neck. 2003;25:982–989.
   PubMed Web of Science ®Google Scholar
• Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 2003;61:751–758.
   PubMed Web of Science ®Google Scholar
• Nguyen TV, Yueh B. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer. 2002;95:553–562.
   PubMed Web of Science ®Google Scholar
• Aebersold DM, Beer KT, Laissue J, Djonov V, Greiner RH. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys. 2000;48:17–25.
   PubMed Web of Science ®Google Scholar
• Goldberg G. Human fibroblasts collagenase: complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem. 1986;261(14):6600–6605.
   PubMed Web of Science ®Google Scholar
• Impola U, Cuccuru MA, Masala MV, Jeskanen L, Cottoni F, Saarialho-Kere U. Preliminary communication: matrix metalloproteinases in Kaposi's sarcoma. Br J Dermatol. 2003;149:905–907.
   PubMed Web of Science ®Google Scholar
• Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer. 2003;103:709–716.
   PubMed Web of Science ®Google Scholar
• Jayade BV, Bhat K, Patil BR, Nayak R, Sant A. Histological significance of p53 gene expression in squamous cell carcinoma of the buccal mucosa. J Maxillofac Oral Surg. 2009;8(3):205–210.
   Google Scholar
• Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 1999;43(Suppl):S42–S51.
   PubMed Web of Science ®Google Scholar
• Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhönen S, Kähäri V. Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck. 2006;28:225–234.
   PubMed Web of Science ®Google Scholar
• Matrisian LM. Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J. 1985;4(6):1435–1440.
   PubMed Web of Science ®Google Scholar
• Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14(7):455–463.
   PubMed Web of Science ®Google Scholar
• Murray GI. Matrix metalloproteinases: a multifunctional group of molecules. J Pathol. 2001;195:135–137.
   PubMed Web of Science ®Google Scholar
• Ranuncolo SM, Matos E, Loria D, Vilensky M, Rojo R, Bal de Kier Joffé E, Inés Puricelli L. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Cancer. 2002;94:1483–1491.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–68.
   PubMed Web of Science ®Google Scholar
• Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990;348:699–704.
   PubMed Web of Science ®Google Scholar
• Nebeshima K. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys. 1991;285(1):90–96.
   PubMed Web of Science ®Google Scholar
• Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol. 2005;131:340–346.
   PubMed Web of Science ®Google Scholar
• Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck. 1999;21:627–638.
   PubMed Web of Science ®Google Scholar
• Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer. Oral Oncol. 1999;35:227–233.
   PubMed Web of Science ®Google Scholar
• Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP, Graner E. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol. 2002;20:189–194.
   PubMed Web of Science ®Google Scholar
• Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 1999;17:315–323.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Investig. 1999;103:1237–1241.
   PubMed Web of Science ®Google Scholar
• Aebersold DM. [Angiogenesis as prognostic factor in malignant tumors]. Ther Umsch. 1998;55:462–463. German.
   PubMedGoogle Scholar
• Burri PH, Hlushchuk R, Djonov V. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn. 2004;231:474–488.
   PubMed Web of Science ®Google Scholar
• Djonov V, Cresto N, Aebersold DM, Burri PH, Altermatt HJ, Hiristic M. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Oncol. 2002;21:25–30.
   PubMed Web of Science ®Google Scholar
• Djonov V, Hogger K, Sedlacek R, Laissue J, Draeger A. MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol. 2001;195:147–155.
   PubMed Web of Science ®Google Scholar
• Rautava J, Luukkaa M, Heikinheimo K, Alin J, Grenman R, Happonen RP. Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol. 2007;43(9):911–919.
   PubMed Web of Science ®Google Scholar
• Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P. Extracellular matrix metalloproteinase inducer stimulates tumour angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res. 2005;65:3193–3199.
   PubMed Web of Science ®Google Scholar
• Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J. 1990;4:1577–1590.
   PubMed Web of Science ®Google Scholar
• Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol. 2000;31:895–904.
   PubMed Web of Science ®Google Scholar
• Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol. 2005;90:81–88.
   PubMed Web of Science ®Google Scholar
• Chiang WC, Wong YK, Lin SC, Chang KW, Liu CJ. Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression. Oral Dis. 2006;12(1):27–33.
   PubMed Web of Science ®Google Scholar
• Impola U, Jeskanen L, Ravanti L, Syrjänen S, Baldursson B, Kähäri VM, Saarialho-Kere U. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol. 2005;152:720–726.
   PubMed Web of Science ®Google Scholar
• Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H. Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells. Clin Cancer Res. 2004;10:8243–8249.
   PubMed Web of Science ®Google Scholar
• Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer. 2002;95:1902–1910.
   PubMed Web of Science ®Google Scholar
• Aebersold DM, Landt O, Berthou S, Gruber G, Beer KT, Greiner RH, Zimmer Y. Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx. Oncogene. 2003;22:8519–8523.
   PubMed Web of Science ®Google Scholar
• Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A. The invasive front of carcinomas: the most important area for tumour prognosis? Anticancer Res. 1998;18:4757–4764.
   PubMed Web of Science ®Google Scholar
• Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, Hayashi R, Ebihara S, Cho JS, Ochiai A. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2004;10:166–172.
   PubMed Web of Science ®Google Scholar
• Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, Vylliotis A. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol. 2008;34(4):450–455.
   PubMed Web of Science ®Google Scholar
• De Vicente JC, Recio OR, Pendas SL, Lopez-Arranz JS. Oral squamous cell carcinoma of the mandibular region: a survival study. Head Neck. 2001;23:536–543.
   PubMed Web of Science ®Google Scholar
• Garcia-Gomez JM, Vidal C, Vicente J, Marti-Bonmati L, Robles M. Medical decision support system for diagnosis of soft tissue tumors based on distributed architecture. Conf Proc IEEE Eng Med Biol Soc. 2004;5:3225–3228.
   PubMedGoogle Scholar
• Hong SD, Hong SP, Lee JI, Lim CY. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol. 2000;36:207–213.
   PubMed Web of Science ®Google Scholar
• Kosukawa J. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol. 1993;99(1):18–23.
   PubMed Web of Science ®Google Scholar
• Tokumaru Y, Fujii M, Otani Y, Kameyama K, Imanishi Y, Igarashi N. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett. 2000;150:15–21.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park C, Seiki. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 1997;79:139–144.
   PubMed Web of Science ®Google Scholar
• Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol. 2004;202:14–22.
   PubMed Web of Science ®Google Scholar
• Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res. 2004;10:634–640.
   PubMed Web of Science ®Google Scholar
• Vihinen P, Ala-aho R, Kahari VM. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 2005;5:203–220.
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 2000;6:4823–4830.
   PubMed Web of Science ®Google Scholar
• Gottschlich S, Koch R, Gorogh T, Holtmeier C, Hoffmann M, Rudert H, Maune S. [Collagenase 3 mRNA expression in squamous epithelial carcinomas of the oropharynx]. HNO. 2002;50:43–47. German.
   PubMed Web of Science ®Google Scholar
• Werner JA, Rathcke IO, Mandic R. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis. 2002;19:275–282.
   PubMed Web of Science ®Google Scholar